Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Guangdong Dowstone Technology Co., Ltd. (300409.SZ)
Foshan, CN
Guangdong Dowstone Technology Co., Ltd. is a manufacturer and distributor of ceramic products, with its business operations extending throughout China and internationally. The company's activities span the entire lifecycle from research and development (R&D) through production, processing, and sales, alongside offering associated technical services. It works with a broad spectrum of materials, including inorganic non-metallic substances, polymer compounds, and various ceramic-specific items like color glazes, raw materials, additives, and electromechanical components. Additionally, the company actively exports its proprietary products and technologies. Established in 2007, its primary base of operations is in Foshan, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.95% | -10.99% | -17.27% | -25.76% | +3.48% | -0.93% | +62.39% | +77.25% | +55.59% | +1.23% | +383.30% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2025-01 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+5.2% ★ Q1'26: +27.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+151.9% ★ Q1'26: +117.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+6.2% Q1'26: -53.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+9.7% ★ Q1'26: +9.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+6.9% ★ Q1'26: +5.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+28.6% Q1'26: +13.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.42× Q1'26: 4.78× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
7.30B
est: 13.80B (-47.1%)
|
7.75B
est: 9.00B (-13.9%)
|
8.16B
est: 8.16B (0.0%)
|
9.03B
9.03B – 9.03B
+10.6% YoY
|
10.76B
10.76B – 10.76B
+19.2% YoY
|
13.13B
13.13B – 13.13B
+22.0% YoY
|
| EBITDA |
496.07M
est: 1.24B (-59.9%)
|
629.17M
est: 877.03M (-28.3%)
|
1.19B
est: 794.98M (+49.9%)
|
879.52M
879.52M – 879.52M
+10.6% YoY
|
1.05B
1.05B – 1.05B
+19.2% YoY
|
1.28B
1.28B – 1.28B
+22.0% YoY
|
| EBIT |
149.95M
est: 729.21M (-79.4%)
|
304.65M
est: 533.97M (-42.9%)
|
787.56M
est: 484.02M (+62.7%)
|
535.49M
535.49M – 535.49M
+10.6% YoY
|
638.21M
638.21M – 638.21M
+19.2% YoY
|
778.82M
778.82M – 778.82M
+22.0% YoY
|
| Net Income |
-27.89M
|
156.86M
est: 358.20M (-56.2%)
|
506.85M
est: 619.38M (-18.2%)
|
723.86M
723.86M – 723.86M
+16.9% YoY
|
902.95M
902.95M – 902.95M
+24.7% YoY
|
1.05B
1.05B – 1.05B
+16.5% YoY
|
| SGA |
458.31M
est: 912.54M (-49.8%)
|
540.03M
est: 496.00M (+8.9%)
|
304.58M
est: 449.60M (-32.3%)
|
497.42M
497.42M – 497.42M
+10.6% YoY
|
592.83M
592.83M – 592.83M
+19.2% YoY
|
723.44M
723.44M – 723.44M
+22.0% YoY
|
| EPS |
-0.05
|
0.27
est: 0.48 (-43.8%)
|
0.68
est: 0.83 (-18.1%)
|
0.97
0.97 – 0.97
+16.9% YoY
|
1.21
1.21 – 1.21
+24.7% YoY
|
1.41
1.41 – 1.41
+16.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-28 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-27 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-26 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-25 | B- | 2/5 | 1/5 | 4/5 | 4/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-22 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-21 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-20 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-19 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-18 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | B- | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | B- | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-15 | B- | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dongjie Hu | Financial Director | — | male |
| Jianan Wang | Deputy General Manager | — | male |
| Xinlu Liu | Deputy General Manager | — | male |
| Yi Zhang | GM & Director | — | male |
| Yunxi Pan | Secretary to the Board | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300409.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
